OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review
Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 9, pp. 946-950
Closed Access | Times Cited: 14
Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 9, pp. 946-950
Closed Access | Times Cited: 14
Showing 14 citing articles:
Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19
Takahiro Takazono, Satoki Fujita, Takuji Komeda, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 8, pp. 1821-1833
Open Access | Times Cited: 13
Takahiro Takazono, Satoki Fujita, Takuji Komeda, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 8, pp. 1821-1833
Open Access | Times Cited: 13
Ensitrelvir Fumaric Acid: First Approval
Yahiya Y. Syed
Drugs (2024) Vol. 84, Iss. 6, pp. 721-728
Closed Access | Times Cited: 10
Yahiya Y. Syed
Drugs (2024) Vol. 84, Iss. 6, pp. 721-728
Closed Access | Times Cited: 10
Advancements in the development of antivirals against SARS-Coronavirus
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
SARS-CoV-2 replication and drug discovery
Farah Nazir, Arnaud John Kombe Kombe, Zunera Khalid, et al.
Molecular and Cellular Probes (2024) Vol. 77, pp. 101973-101973
Open Access | Times Cited: 4
Farah Nazir, Arnaud John Kombe Kombe, Zunera Khalid, et al.
Molecular and Cellular Probes (2024) Vol. 77, pp. 101973-101973
Open Access | Times Cited: 4
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Comparative Study of Ensitrelvir and Symptomatic Therapy in Healthcare Workers with Mild COVID-19: A Single Center Retrospective Analysis in Chiba, Japan.
Jun Hirai, Yuki Hanai
Journal of Infection and Chemotherapy (2025), pp. 102668-102668
Closed Access
Jun Hirai, Yuki Hanai
Journal of Infection and Chemotherapy (2025), pp. 102668-102668
Closed Access
Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review
Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs
Shin Aoki, Tomohiro Tanaka, Kenta Yokoi, et al.
Chemical and Pharmaceutical Bulletin (2025) Vol. 73, Iss. 4, pp. 355-368
Open Access
Shin Aoki, Tomohiro Tanaka, Kenta Yokoi, et al.
Chemical and Pharmaceutical Bulletin (2025) Vol. 73, Iss. 4, pp. 355-368
Open Access
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study
Masaya Yamato, M. Kinoshita, Yuki Yoshida, et al.
Infectious Diseases and Therapy (2025)
Open Access
Masaya Yamato, M. Kinoshita, Yuki Yoshida, et al.
Infectious Diseases and Therapy (2025)
Open Access
COVID-19-induced thrombotic microangiopathy in patients with multiple myeloma receiving carfilzomib treatment
K Takikawa, M. Sota, Shiori Nakashima, et al.
International Journal of Hematology (2025)
Closed Access
K Takikawa, M. Sota, Shiori Nakashima, et al.
International Journal of Hematology (2025)
Closed Access
Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series
Shuichi Abe, Dhammika Leshan Wannigama, Yu Suzuki, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101522-101522
Open Access | Times Cited: 2
Shuichi Abe, Dhammika Leshan Wannigama, Yu Suzuki, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101522-101522
Open Access | Times Cited: 2
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19
Thijs Feuth, Jarmo Oksi
CMI Communications (2024) Vol. 1, Iss. 2, pp. 100009-100009
Open Access
Thijs Feuth, Jarmo Oksi
CMI Communications (2024) Vol. 1, Iss. 2, pp. 100009-100009
Open Access
Box-Behnken Design Assisted AQbD Approach for the Optimization and Quality Assessment of Ensitrelvir in Bulk and Dosage forms by RP-HPLC
B Sivagami, M. Dinesh, Pavan Kumar, et al.
Biosciences Biotechnology Research Asia (2024) Vol. 21, Iss. 4, pp. 1593-1604
Open Access
B Sivagami, M. Dinesh, Pavan Kumar, et al.
Biosciences Biotechnology Research Asia (2024) Vol. 21, Iss. 4, pp. 1593-1604
Open Access
